GlassScriptPhysician profile
Rangarajan Arunachalam
NPI 1467562611
$6,017.39
in general payments reported to CMS, 2019-2025
27 companies · $586 in 2025
The $586 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $779 · 2021: $175 · 2022: $776 · 2023: $3,053 · 2024: $334 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,186 · Food and Beverage: $1,787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,186.03 |
| Food and Beverage | $1,787.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $1,612.78 | 2023 | Diamondback Coronary |
| Boston Scientific Corporation | $1,180.98 | 2019-2025 | Avvigo Guidance System, Rotapro |
| Abbott Laboratories | $1,027.97 | 2019-2025 | Diamondback Coronary, Pressurewire, Diamondback Peripheral |
| Edwards Lifesciences Corporation | $268.62 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $247.01 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $219.99 | 2019-2023 | Farxiga |
| Pfizer INC. | $197.84 | 2019-2025 | |
| Canon Medical Systems USA, INC. | $193.92 | 2025 | Interventional Angiography System |
| Philips North America LLC | $187.26 | 2022-2025 | Azurion 7 M20 |
| Abiomed | $186.25 | 2021-2025 | |
| Amgen INC. | $148.37 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $81.60 | 2023-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $71.32 | 2019-2022 | |
| Shockwave Medical, INC | $67.75 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Ekos Corporation | $53.42 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $48.43 | 2019-2024 | Xarelto |
| Terumo Medical Corporation | $33.96 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $33.34 | 2023 | Verquvo |
| Scpharmaceuticals INC. | $23.40 | 2025 | |
| Alnylam Pharmaceuticals INC. | $20.59 | 2022 | |
| Novo Nordisk INC | $20.33 | 2024 | Ozempic |
| Cordis US Corp. | $18.92 | 2021 | |
| Imperative Care, INC | $18.20 | 2025 | Symphony Catheter |
| Otsuka America Pharmaceutical, INC. | $16.94 | 2019 | |
| Medtronic Vascular, INC. | $14.04 | 2019 | |
| Teleflex LLC | $12.80 | 2019 | |
| Amarin Pharma, INC. | $11.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rangarajan Arunachalam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.